Advance Digital Care (PECAN)

Type of financing

Derogatory

Beneficiary

Medical device operator

Context of use

Facility / City

Purpose of the system

Accelerate reimbursement for therapeutic digital medical devices (DMDs) or remote medical monitoring activities.

To get off to a good start

PECAN allows for one year of exceptional coverage by the French national health insurance system for sufficiently mature solutions.
This early phase allows the operator to finalize the demonstration of clinical and/or organizational benefits while already being reimbursed.

DISCOVER

I check whether I am eligible for digital advance payment (PECAN).

2 MIN

REGULATIONS

Getting advance coverage: my roadmap

Steps to follow to successfully claim your DMN reimbursement

20 min

DISCOVER

How can I demonstrate the clinical and/or organizational benefits of my solution?

1 MIN

REFUND

Financial compensation from PECAN

Rates

2 MIN

The role of PECAN

Digital advance care planning in a nutshell.

Interview with Vincent Vercamer (Project Director - Digital Health Delegation).

PECAN

The major stages of the journey

I check whether my digital medical device is eligible.

I submit my applications on the ANS Convergence platform and the HAS Sésame platform.

My eligibility is reviewed by the ANS and the HAS. I submit all my evidence regarding interoperability and security requirements to the ANS. I then receive the AR from the ministers.

My application is first reviewed by the CNEDiMTS and the ANS, and then, once they have approved it, it will be evaluated by the ministers.

Following approval by the ministers, I am reimbursed one year before coming under common law.

Common law repayment phase

If my solution is a digital therapeutic medical device, I have six months from the start of early coverage to apply for inclusion on the list of products and services (LPP) under a brand name.
If my solution is a remote monitoring activity, I have nine months from the start of advance coverage to apply for registration on the list of medical remote monitoring activities (LATM) under a generic name or brand name.

The evidence of clinical benefit or, failing that, progress in the organization of care in the case of remote monitoring provided by my solution and demonstrated in my file is evaluated by the HAS.

If the decision of the ministers responsible for health and social security is favorable, my solution will be covered by common law for a period of several years, renewable. Before the expiration date, I will renew my request for coverage.

Watch the replay of the webinar held on April 25, 2024

Advance digital coverage of medical devices: a new reimbursement method

Check out the webinar support

Early adoption of digital medical devices, current events

Consult the reference documents

Consult the complete list of items that the operator must supply on the Ministry's website. Consult the safety and interoperability guidelines FAQ PECAN numéro 2.pdf pdf ( 266.27 KB )

G_NIUS saves you time

Remote Monitoring Reimbursement Fact sheet

This mechanism allows access to the market for remote surveillance activities under common law.

Product and service fact sheet

Inclusion on the list of products and services (LPP) allows for direct reimbursement of the product or service by the Health Insurance.

Want to learn more about PECAN?

Please ask your question, our teams will get back to you as soon as possible.

G_NIUS supports digital health project leaders in understanding the regulatory framework, identifying funding opportunities, and connecting with the ecosystem to accelerate innovation in France.